The Facts About the $35 Insulin Copay Cap in Medicare June 12, 2024 Blog This brief describes the facts about actions taken under both the Trump and Biden Administrations related to capping insulin copayments for people with Medicare and explains the differences between their approaches.
Household Health Spending Calculator September 10, 2024 Interactive This interactive tool, updated with 2022 data, helps users understand health care costs vary by family size, income, insurance, and health status. Use the dropdown menus to explore scenarios and trends in household health spending.
Frederick O. Terrell June 16, 2022 Person Frederick O. Terrell is Vice Chairman of Investment Banking for Wells Fargo & Company. He is formerly a Senior Advisor to Centerbridge Partners, L.P., a multi-strategy investment platform where he focused on investments in the financial services and technology sectors. Prior to joining Centerbridge, he was Executive Vice Chairman of…
5 Charts About Public Opinion on the Affordable Care Act February 22, 2024 Poll Finding A look at public opinion about the ACA and its provisions, including protections for people with pre-existing conditions and the impact of the law on families.
KFF Health Misinformation Monitor Volume 4 July 25, 2024 Page In this Monitor, we explore how ongoing misinformation about the safety and efficacy of COVID-19 vaccines may affect the acceptance of new vaccine recommendations. First, we examine the false and misleading claims underlying the Kansas Attorney General’s lawsuit against Pfizer. We also discuss the CDC’s most recent vaccine.
Medicare Advantage Quality Bonus Payments Will Total at Least $11.8 Billion in 2024 September 11, 2024 Issue Brief In 2024, federal spending on Medicare Advantage bonus payments will total at least $11.8 billion, as nearly three-quarters of enrollees are in a plan that received bonus payments. The average bonus payment is higher for employer plans and lowest for special needs plans, raising questions about the implication of the quality bonus program for equity.
Again, No Medicaid September 12, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman explains why Medicaid, despite former President Donald Trump’s silence on the topic, warrants greater attention given the potential for drastic changes or cuts to it should Republicans win control in the election.
The Health Misinformation Monitor: Vaccine Misinformation Spreads as Children Head Back to School September 12, 2024 Page This edition highlights vaccine hesitancy and misinformation around MMR (measles, mumps, and rubella) vaccines as children return to school and measles cases resurge in parts of the U.S. It also examines emerging narratives around COVID-19 vaccine misinformation following the FDA approval of COVID-19 boosters and false claims linking mpox to the vaccines.
KFF Health Tracking Poll September 2024: Support for Reducing Prescription Drug Prices Remains High, Even As Awareness of IRA Provisions Lags September 13, 2024 Poll Finding More than two years ago President Biden signed into law Medicare drug pricing provisions in the Inflation Reduction Act. KFF’s September Health Tracking Poll examines voter’s views on these provisions and finds that large majorities of voters are unaware of the provisions despite reporting support for them.